Other – Page 5 – Communicable Diseases Research

A Novel Deep Learning and Ensemble Learning Mechanism for Delta-Type COVID-19 Detection

델타형 COVID-19 탐지를 위한 새로운 딥 러닝 및 앙상블 학습 메커니즘

Article

Published on 2022-07-082022-09-11
Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 치료기술, 치료제,

Joint impact of key air pollutants on COVID-19 severity: prediction based on toxicogenomic data analysis

주요 대기 오염 물질이 COVID-19 심각도에 미치는 공동 영향: 독성 유전체 데이터 분석을 기반으로 한 예측

Article

Published on 2022-07-072022-09-11
Journal: Arhiv za higijenu rada i toksikologiju [Category] 유전자 메커니즘,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Air pollution AML Analysis binding biological process biological processe biological processes carbon monoxide CEBPA citokini Comparative Complication coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 complication COVID-19 complications COVID-19 patient COVID-19 transmission CTD cytokine Cytokine storm Cytokines Data analysis death rate determine disease disease complications Diseases DisGeNET dušikov dioksid English Fever Final GeneMANIA Genes identify IL10 IL1B IL6 in silico indicate Inflammation interactions komplikacije bolesti lebdeće čestice molecular molecular function network nitrogen nitrogen dioxide onečišćivači zraka Other ozon Ozone Particulate Particulate matter pathway Periodic fever physical poremećaj funkcije gena researcher resulting SARS-CoV-2 severe acute respiratory syndrome Coronavirus severity sulphur dioxide sumporov dioksid syndrome the cytokine storm TNF TNFRSF1A ugljikov monoksid.
[DOI] 10.2478/aiht-2022-73-3631 PMC 바로가기 [Article Type] Article

Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)

Randomized Controlled Trial

Published on 2022-07-012022-10-04
Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 신약개발, 임상, 치료법,

[키워드] absence Adults adverse events adverse outcome alleviation of symptoms Analysis ARMS Blood Ciclesonide clinical Comorbidity control arm COVID-19 COVID-19 outpatient criteria Day death died Efficacy Endpoint European Medicines Agency Evidence Evolution Follow-up Hospitalization Hospitalized improvement Inhaled inhaled corticosteroid inhaled corticosteroids intent-to-treat interim analysis interquartile range involved median age median time men Open-label Other outcome Outpatient outpatients Oxygen therapy parameter participant patients with COVID-19 primary efficacy endpoint primary endpoint randomised controlled trial Randomized controlled trial Randomly reached reducing reported risk risk factor RT-PCR Safety Monitoring Board scale secondary sustained Symptom the WHO Treatment Trial women worsening
[DOI] 10.1016/j.cmi.2022.02.031 PMC 바로가기 [Article Type] Randomized Controlled Trial

HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients

Conference abstract

Published on 2022-07-012022-10-05
Journal: Value in health : the journal of the International [Category] 바이오마커,

[키워드] Control COVID-19 Impact Other telehealth Type
[DOI] 10.1016/j.jval.2022.04.957 [Article Type] Conference abstract

Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages

COVID-19 환자의 비인두 샘플에서 SARS-CoV-2 분석은 다른 계통과 관련하여 우려되는 변이체의 성장 특성을 배치하여 인구 변이 및 다양한 표현형을 보여줍니다

Article

Published on 2022-06-292022-09-11
Journal: mSphere [Category] COVID19(2023년), SARS, 변종,

[키워드] A549 cells Alpha amplified Beta Beta variant Biology biology of SARS-CoV-2 causative agent Cell Cell culture cell line cells change characterized clinical isolates clinical samples concern Context coronavirus COVID-19 Delta disease effective Evolution genetic diversity genetics genome sequence genomic global pandemic growth growth kinetics hACE2 hospitalized patient hospitalized patients humans immune evasion increased risk indicated Infection isolate isolates less Lineage minor minor genomic variants morbidity Mortality Nasopharyngeal swab nasopharyngeal swabs New no difference not different omicron Other other coronaviruses other variant other variants pandemic patients pattern planet Population Population dynamics Population genetics Postinfection preserved property Research RNA RNA sequencing Sample SARS-CoV-2 SARS-CoV-2 genome SARS-CoV-2 genomes sequence several variants Spread suggested Transmission vaccination Vaccine Variability variant variants variants of concern variants of SARS-CoV-2 Variation Vero E6 Vero E6 cell VERO E6 cells virus Virus evolution VoC VOCs widespread with COVID-19
[DOI] 10.1128/msphere.00913-21 PMC 바로가기 [Article Type] Article

Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice

SARS-CoV-2에 감염된 마우스의 폐에서 염증의 사이토카인 및 지질 매개체

Article

Published on 2022-06-242022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Alanine Analysis analyzed animal animal model animal models Blood blood clot Blood clots characterized chemokine chemokines circulating clinical manifestation Concentration coronavirus 2 coronavirus disease coronavirus disease 19 correlated COVID-19 Cytokines D-dimer D-dimers different time point different time points elevated ethanolamide event events Features Genes glycerol glycine hallmark highlight histology Human hydroxy indicated Infection Inflammation inflammatory mediator Inflammatory mediators interferons K18-ACE2 knowledge leukocyte leukocyte infiltration Lipid lipid mediator lipid mediators of inflammation lipids lung Lung inflammation lung tissue lung tissues lung viral load Lungs mass spectrometry Measures mediator mice modulation Other Pathogenesis pathology pathophysiological performed PGF plasma Post-infection produced prostaglandin reduced Replication RNA-seq analysis robust SARS-CoV-2 SARS-COV-2 infection Severe acute respiratory syndrome severe acute respiratory syndrome coronavirus 2 severe COVID-19 significantly Support Tandem mass spectrometry therapeutic strategy transcriptomic transgenic mice treat uninfected vasculature viral replication
[DOI] 10.3389/fimmu.2022.893792 PMC 바로가기 [Article Type] Article

Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants

렘데시비르와 GS-441524는 델타, 오미크론 및 기타 신종 SARS-CoV-2 변이체에 대해 항바이러스 활성을 유지한다

Article

Published on 2022-06-212022-09-11
Journal: Antimicrobial Agents and Chemotherapy [Category] COVID19(2023년), SARS, 변종, 치료제,

[키워드] 50% effective concentration activity acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Antiviral antiviral activity Antiviral agents Antiviral treatment change circulating Combination conserved coronavirus COVID-19 Delta disease severity Effectiveness ELISA enzyme-linked immunosorbent enzyme-linked immunosorbent assay Evidence evidence of exhibited fold Genetic variation GS-441524 highlight isolate Neutralizing antibodies Nsp12 nucleoside omicron Omicron variants Other P323L pandemic parent nucleoside potency predominant prevalent RdRP RDV reduction remained Remdesivir retained RNA-dependent RNA polymerase SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants sequence sequences severe acute respiratory syndrome Coronavirus Spread Substitution Support susceptible sustained tested the SARS-CoV-2 Treatment Vaccine variant variants Variation Veklury Viral transmission virus viruses WA1
[DOI] 10.1128/aac.00222-22 PMC 바로가기 [Article Type] Article

Infodemiological study on the impact of the COVID-19 pandemic on increased headache incidences at the world level

Research

Published on 2022-06-172022-10-05
Journal: Scientific Reports [Category] 치료기술, 치료법,

Broadly Neutralizing Antibodies to SARS-CoV-2 Provide Novel Insights Into the Neutralization of Variants and Other Human Coronaviruses

SARS-CoV-2에 대한 광범위 중화 항체는 변이체 및 기타 인간 코로나바이러스 중화에 대한 새로운 통찰력 제공

Article

Published on 2022-06-162022-09-11
Journal: Frontiers in Cellular and Infection Microbiology [Category] COVID19(2023년), MERS, SARS, 변종, 진단,

Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia

Article

Published on 2022-06-152022-10-04
Journal: PLoS ONE [Category] 신약개발,